01.09.2016 • News

China Petchems Firms Plan CO2 Benchmarking

(c) Kodda/Shutterstock
(c) Kodda/Shutterstock

Chinese refiners and petrochemical producers plan to set up a system for benchmarking their carbon dioxide (CO2) emissions as the first step toward setting up an emissions market for the sector. The China Petroleum and Chemical Industry Federation (CPCIF), a lobbying group for the country’s oil industry, said in its China Chemical Industry News newsletter it will make a proposal by September on how to set benchmarks for the CO2 produced while manufacturing products ranging from diesel fuel to benzene.

According to CPCIF, the benchmarks will be used to set CO2 emissions caps for nearly 2,400 companies in the sector under the national carbon market slated to start next year. This will help create reduction targets for the large petrochemical and chemical plants said to account for up to 70% of the sector's CO2 emissions. China is the world's second-largest oil consumer behind the US. Altogether 8,000 companies in eight industries are planned to be included in the national carbon trading scheme, including players in the power, steel, cement and transportation sectors.

Petrochemical and other chemical producers participating in China's domestic carbon market will account for one-third of all companies participating nationally, Li Yongliang, a CPCIF official, told China Chemical Industry News.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read